Malignant melanoma: Treatments emerging, but early detection is still key

Paul Masci, DO
Department of Hematology/Oncology and Center for Cancer Drug Discovery and Development, The Cleveland Clinic

Ernest C. Borden, MD
Director, Center for Cancer Drug Discovery and Development and Department of Hematology/Oncology, Taussig Cancer Center, The Cleveland Clinic

Address: Ernest C. Borden, MD, Taussig Cancer Center, R4, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Paul Masci, DO
Department of Hematology/Oncology and Center for Cancer Drug Discovery and Development, The Cleveland Clinic

Ernest C. Borden, MD
Director, Center for Cancer Drug Discovery and Development and Department of Hematology/Oncology, Taussig Cancer Center, The Cleveland Clinic

Address: Ernest C. Borden, MD, Taussig Cancer Center, R4, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Paul Masci, DO
Department of Hematology/Oncology and Center for Cancer Drug Discovery and Development, The Cleveland Clinic

Ernest C. Borden, MD
Director, Center for Cancer Drug Discovery and Development and Department of Hematology/Oncology, Taussig Cancer Center, The Cleveland Clinic

Address: Ernest C. Borden, MD, Taussig Cancer Center, R4, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]